Accelerate Stock Market Value


USD 0.75  0.08  9.64%   

Accelerate Diagnostics' market value is the price at which a share of Accelerate Diagnostics stock trades on a public exchange. It measures the collective expectations of Accelerate Diagnostics investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Accelerate Diagnostics and determine expected loss or profit from investing in Accelerate Diagnostics over a given investment horizon. Please continue to Accelerate Diagnostics Correlation, Accelerate Diagnostics Volatility and Accelerate Diagnostics Alpha and Beta module to complement your research on Accelerate Diagnostics.

Is Accelerate Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accelerate Diagnostics. If investors know Accelerate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accelerate Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
74.3 M
Quarterly Revenue Growth YOY
Return On Assets
The market value of Accelerate Diagnostics is measured differently than its book value, which is the value of Accelerate that is recorded on the company's balance sheet. Investors also form their own opinion of Accelerate Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Accelerate Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accelerate Diagnostics' market value can be influenced by many factors that don't directly affect Accelerate Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accelerate Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Accelerate Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accelerate Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Accelerate Diagnostics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Accelerate Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Accelerate Diagnostics.
No Change 0.00  0.0 
In 31 days
If you would invest  0.00  in Accelerate Diagnostics on November 5, 2022 and sell it all today you would earn a total of 0.00 from holding Accelerate Diagnostics or generate 0.0% return on investment in Accelerate Diagnostics over 30 days. Accelerate Diagnostics is related to or competes with Acer Therapeutics, Arbutus Biopharma, Achieve Life, Abeona Therapeutics, AC Immune, Aurora Cannabis, and Aclaris Therapeutics. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infection... More

Accelerate Diagnostics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Accelerate Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Accelerate Diagnostics upside and downside potential and time the market with a certain degree of confidence.

Accelerate Diagnostics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Accelerate Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Accelerate Diagnostics' standard deviation. In reality, there are many statistical measures that can use Accelerate Diagnostics historical prices to predict the future Accelerate Diagnostics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Accelerate Diagnostics in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Accelerate Diagnostics. Your research has to be compared to or analyzed against Accelerate Diagnostics' peers to derive any actionable benefits. When done correctly, Accelerate Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Accelerate Diagnostics.

Accelerate Diagnostics Backtested Returns

Accelerate Diagnostics secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had -0.1% of return per unit of standard deviation over the last 3 months. Macroaxis philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Accelerate Diagnostics exposes twenty-seven different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Accelerate Diagnostics mean deviation of 4.96, and Risk Adjusted Performance of (0.15) to double-check the risk estimate we provide.
The firm shows a Beta (market volatility) of 1.4225, which signifies a somewhat significant risk relative to the market. Let's try to break down what Accelerate's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Accelerate Diagnostics will likely underperform. Even though it is essential to pay attention to Accelerate Diagnostics historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Accelerate Diagnostics exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Accelerate Diagnostics has an expected return of -0.79%. Please be advised to confirm Accelerate Diagnostics information ratio and the relationship between the value at risk and price action indicator to decide if Accelerate Diagnostics performance from the past will be repeated at some point in the near future.



Very good predictability

Accelerate Diagnostics has very good predictability. Overlapping area represents the amount of predictability between Accelerate Diagnostics time series from 5th of November 2022 to 20th of November 2022 and 20th of November 2022 to 5th of December 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Accelerate Diagnostics price movement. The serial correlation of 0.8 indicates that around 80.0% of current Accelerate Diagnostics price fluctuation can be explain by its past prices.
Correlation Coefficient0.8
Spearman Rank Test0.68
Residual Average0.0
Price Variance0.01

Accelerate Diagnostics lagged returns against current returns

Autocorrelation, which is Accelerate Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Accelerate Diagnostics' stock expected returns. We can calculate the autocorrelation of Accelerate Diagnostics returns to help us make a trade decision. For example, suppose you find that Accelerate Diagnostics stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   

Accelerate Diagnostics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Accelerate Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Accelerate Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Accelerate Diagnostics stock over time.
   Current vs Lagged Prices   

Accelerate Diagnostics Lagged Returns

When evaluating Accelerate Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Accelerate Diagnostics stock have on its future price. Accelerate Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Accelerate Diagnostics autocorrelation shows the relationship between Accelerate Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Accelerate Diagnostics.
   Regressed Prices   

Be your own money manager

Our tools can tell you how much better you can do entering a position in Accelerate Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now


Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Pair Trading with Accelerate Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Accelerate Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Accelerate Diagnostics

+0.64ALLOAllogene Therapeutics Normal TradingPairCorr

Moving against Accelerate Diagnostics

-0.76MRNAModerna Potential GrowthPairCorr
-0.68AERIAerie Pharmace DelistingPairCorr
-0.58ASNDAscendis Pharma AS Normal TradingPairCorr
The ability to find closely correlated positions to Accelerate Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Accelerate Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Accelerate Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Accelerate Diagnostics to buy it.
The correlation of Accelerate Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Accelerate Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Accelerate Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Accelerate Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Accelerate Diagnostics Correlation, Accelerate Diagnostics Volatility and Accelerate Diagnostics Alpha and Beta module to complement your research on Accelerate Diagnostics. Note that the Accelerate Diagnostics information on this page should be used as a complementary analysis to other Accelerate Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Accelerate Stock analysis

When running Accelerate Diagnostics price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Accelerate Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Accelerate Diagnostics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Accelerate Diagnostics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...